An official website of the United States government

Citation
Warram, James (2013). The Genetics of Kidneys in Diabetes (GoKind) (Version 2) [Dataset] NIDDK Central Repository. https://doi.org/10.58020/vj89-zr33
Data Availability Statement
Data from the The Genetics of Kidneys in Diabetes (GoKind) [(Version 2) https://doi.org/10.58020/vj89-zr33] reported here are available for request at the NIDDK Central Repository (NIDDK-CR) website, Resources for Research (R4R), https://repository.niddk.nih.gov/.
Acknowledgement Statement
The Genetics of Kidneys in Diabetes (GoKinD) Study was conducted by the GoKinD Investigators and supported by the Juvenile Diabetes Research Foundation (JDRF), the Center for Disease Control (CDC), and the Special Statutory Funding Program for Type 1 Diabetes Research administered by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The resources from the GoKinD study were supplied by NIDDK Central Repository (NIDDK-CR). This manuscript was not prepared under the auspices of the GoKinD study and does not necessarily reflect the opinions or views of the GoKinD study, the CDC, NIDDK-CR, or NIDDK.
Data Package Version
Version 2 (Updated on: Mar 14, 2013)
Resource Availability
  • Data Available for Request
  • Specimens Available for Request
Publications
Explore publications resulting from the use of study resource
View publications (24)

General Description

The Genetics of Kidneys in Diabetes (GoKinD) study was an initiative that aimed to identify genes that are involved in diabetic nephropathy. A large number of individuals with type 1 diabetes were screened to identify two subsets, one with clear-cut kidney disease and another with normal renal status despite long-term diabetes. Those who met additional entry criteria and consented to participate were enrolled. When possible, both parents also were enrolled to form family trios. DNA, serum, plasma, and urine samples and clinical information were collected from participants. A repository of genetic and clinical information was created for use in genetic analysis to investigate the genetic risk factors of the renal disease of Type 1 diabetes, with the ultimate aim of determining pathways for intervention to prevent diabetic kidney disease and allow targeting of preventive therapies.

GWAS data must be requested through dbGAP.

Objectives

The GoKinD study aimed to establish a repository of DNA and clinical information from adults with long-term Type 1 diabetes, with or without kidney disease, along with their parents. Genetic information was used to identify genes involved in diabetic nephropathy and ultimately help to determine pathways for intervention to prevent diabetic kidney disease.

Eligibility Criteria

To be eligible as a case patient, a patient had to have type 1 diabetes (minimum 10 year duration) and severe diabetic nephropathy (ESRD or persistent proteinuria). To be eligible as a control subject, a patient had to have type 1 diabetes for at least 15 years and have normoalbuminuria despite never having been treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and not receiving current treatment with antihypertensive medication. Persistent proteinuria and normoalbuminuria were defined by the urinary albumin to creatinine ratio (ACR) (≥300 and <20 μg/mg, respectively). When both parents of a participant were alive and willing to participate, both were examined to form complete trios (proband and both parents) for analysis.

Further details of eligibility and exclusion requirements are detailed in the study protocol.

Outcome

The GoKinD study created a repository of genetic information of participants with Type 1 diabetes, with and without nephropathy, and their parents to further the study of genetic associations with diabetic nephropathy.

Research Area

Kidney Disease, Diabetes, Multidisciplinary Research

Study Type

Observational

Study Sites

2

Condition

Type 1 Diabetes Mellitus, End Stage Renal Failure, Diabetic Neuropathy

Keywords

End-Stage Renal Disease (ESRD), Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, DNA, Persistent Proteinuria, Diabetes Mellitus, Type 1 (T1D), Genetic Variants, Diabetic Nephropathy

NIDDK Division

Division of Kidney, Urologic, and Hematologic Diseases

3,051
Participants

Target Population
Adults

Public Documents Table
Document Name
Description
Document Type
File Format
Compliance
Download

Non-Public Documents (8)
Non-Public Documents Table
Document Name
Description
Document Type
File Format
Datasets (35)
Datasets Table
Dataset Name
Description
# of Records
# of Variables
File Format(s)
Specimens (44,383)
Specimens Table
Specimen
Count
DNA12399
EBV Transformed Cell Lines11561
Plasma7208
Serum6598
Urine6617